Publications

Subject/Therapeutic Area: Oncology

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Budget impact analysis of tisagenlecleucel for the treatment of paediatric and young adult patients with relapsed or refractory B-cell acute lymphoblastic leukaemia in England.

Author: Hollmann S, Painter C, Hogan A, Wickstead RM, Goyert N, Patel S, Slowley A, Jousseaume E, El Ouagari K, Zhang J, Jewitt K, Ma Q

View

Subject/Therapeutic Area: Cardiovascular

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Estimated economic burden of atrial fibrillation in Germany, Italy, and the UK.

Author: Velleca M, Patel L, Goyert N, Goldstein LJ, Costa G

View

Subject/Therapeutic Area: Oncology

Journal/Conference: ISPOR 23rd Annual International Meeting Baltimore, MD, USA (2018)

Health technology assessment agency appraisal of immuno-oncology cure fraction survival modelling.

Author: Cameron HL, Brown S, Samjoo I, Thompson M

View

Subject/Therapeutic Area: Skin and subcutaneous tissue

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Importance of properly adjusting for heterogeneity among network meta-analyses considering outcomes with multiple pre-defined levels: an illustrative example in psoriasis.

Author: Cameron C, Varu A, Muser E, McElligott S

View

Subject/Therapeutic Area: Other

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Methodological approaches for conducting matching-adjusted indirect treatment comparisons involving multiple randomized controlled trials.

Author: Cameron C, Varu A, Disher T, Hutton B

View

  • Page 1 of 38
  • 1 2 3 38
Copyright © 2018. All Rights Reserved. Cornerstone Research Group